Abstract
Intravenous-to-oral switch strategy is part of an antimicrobial stewardship programme that can reduce the length of hospitalization and lower associated costs. However, intravenous-to-oral switch data in the private healthcare setting in Malaysia is limited. The aim of this study was to explore factors that affect intravenous-to-oral switch decisions in the Malaysian private healthcare. This was a cross-sectional survey among four private hospitals. A total of 225 consultants, pharmacists and nurses were included. Mean assessment was based on a 5-point Likert scale; 1-very unimportant to 5-very important. Microbiology aetiology (4.12±0.93) was the most important clinical factor for deciding suitability of IVOS. Primary consultant preference (3.83±0.98) was the most important non-clinical factor. Respondents agreed that all healthcare professionals needed to be given intravenous-to-oral switch awareness (4.41±0.77). Understanding factors influencing Intravenous-to-oral switch decision and addressing misconceptions in beliefs are important to develop intravenous-to-oral switch and antimicrobial stewardship strategies in private hospitals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have